Average Co-Inventor Count = 5.54
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (12 from 3,923 patents)
2. Glaxosmithkline Biologicals Sa (531 patents)
12 patents:
1. 12252479 - Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
2. 12252478 - Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
3. 11407735 - Crystalline forms of N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
4. 10174006 - Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
5. 9789118 - Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
6. 9624192 - Carbamate/urea derivatives
7. 9320748 - Immunologically useful arginine salts
8. 9273026 - Carbamate/urea derivatives
9. 9034874 - Carbamate/urea derivatives
10. 8829195 - Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
11. 8697739 - Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
12. 8063043 - Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide